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ABSTRACT Calcium release units (CRUs) are junctions between the sarcoplasmic reticulum (SR) and exterior membranes
that mediates excitation contraction (e-c) coupling in muscle cells. In skeletal muscle CRUs contain two isoforms of the
sarcoplasmic reticulum Ca2release channel: ryanodine receptors type 1 and type 3 (RyR1 and RyR3). 1B5s are a mouse
skeletal muscle cell line that carries a null mutation for RyR1 and does not express either RyR1 or RyR3. These cells develop
dyspedic SR/exterior membrane junctions (i.e., dyspedic calcium release units, dCRUs) that contain dihydropyridine recep-
tors (DHPRs) and triadin, two essential components of CRUs, but no RyRs (or feet). Lack of RyRs in turn affects the
disposition of DHPRs, which is normally dictated by a linkage to RyR subunits. In the dCRUs of 1B5 cells, DHPRs are neither
grouped into tetrads nor aligned in two orthogonal directions. We have explored the structural role of RyR3 in the assembly
of CRUs in 1B5 cells independently expressing either RyR1 or RyR3. Either isoform colocalizes with DHPRs and triadin at the
cell periphery. Electron microscopy shows that expression of either isoform results in CRUs containing arrays of feet,
indicating the ability of both isoforms to be targeted to dCRUs and to assemble in ordered arrays in the absence of the other.
However, a significant difference between RyR1- and RyR3-rescued junctions is revealed by freeze fracture. While cells
transfected with RyR1 show restoration of DHPR tetrads and DHPR orthogonal alignment indicative of a link to RyRs, those
transfected with RyR3 do not. This indicates that RyR3 fails to link to DHPRs in a specific manner. This morphological
evidence supports the hypothesis that activation of RyR3 in skeletal muscle cells must be indirect and provides the basis for
failure of e-c coupling in muscle cells containing RyR3 but lacking RyR1 (see the accompanying report, Fessenden et al.,
2000).
INTRODUCTION
Ryanodine receptors (RyRs) are large intracellular channels
(2260 kDa) that play an important role in Ca2 signaling
in a large variety of cells (for reviews see Coronado et al.,
1994; Meissner, 1994; Franzini-Armstrong and Protasi,
1997; Sutko and Airey, 1997). In skeletal muscle, RyRs
allow rapid release of Ca2 from the sarcoplasmic reticulum
(SR) during excitation-contraction (e-c) coupling. Electron
microscopy shows that RyRs, called feet (Franzini-Arm-
strong, 1970), are organized in ordered arrays at specialized
domains of the SR, called junctional SR (jSR). jSR feet are
closely associated with regions of exterior membranes con-
taining a second key molecule in e-c coupling, the dihydro-
pyridine receptors (DHPRs) (Jorgensen et al., 1989; Flucher
et al., 1990; Yuan et al., 1991). DHPRs are L-type Ca2
channels, which act as voltage sensors in skeletal type e-c
coupling (Rios and Brum, 1987; Tanabe et al., 1988; Adams
et al., 1990; Beam et al., 1992). Their interaction with RyRs
is responsible for transduction of exterior membrane depo-
larization into release of Ca2 from the SR during e-c
coupling (Fosset et al., 1983; Rios and Brum, 1987; Tanabe
et al., 1988). The functional unit resulting from the associ-
ation of jSR domains containing RyRs with exterior mem-
brane domains containing DHPRs is called the calcium
release unit (CRU).
Three RyR isoforms, exhibiting different pharmacologi-
cal properties, have been isolated from a variety of tissues:
RyR1, also known as the skeletal isoform (Takeshima et al.,
1989; Zorzato et al., 1990); RyR2, or the cardiac isoform
(Nakai et al., 1990; Otsu et al., 1990); and RyR3, or brain
isoform (Hakamata et al., 1992; Chen et al., 1997). This
terminology is based on the timing and tissue of initial
purification, but further studies have shown that none of the
three isoforms are entirely tissue-specific.
RyR1 and RyR3, or their nonmammalian equivalents 
and , are both present in some skeletal muscles (Airey et
al., 1990; Olivares et al., 1991; Lai et al., 1992; Murayama
and Ogawa, 1992; Giannini et al., 1995; Ledbetter et al.,
1994; O’Brien et al., 1995; Conti et al., 1996). Skeletal
muscles may contain either approximately equal amounts of
RyR1 and RyR3 (muscles in amphibia, reptiles, birds, and
most fish muscles), or RyR1 only (adult fast twitch mam-
malian muscle, some fish muscles), or predominantly RyR1
coexpressed with low levels of RyR3 (late embryonic and
slow twitch mammalian muscles). For reviews see Sor-
rentino and Volpe (1993), Sorrentino (1995), Block et al.
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(1996), Sutko and Airey (1997), and Franzini-Armstrong
and Protasi (1997).
It is clear that RyR1 plays a more important role than
RyR3 both in e-c coupling and in muscle differentiation.
Muscles that express either very little or no RyR3 show
normal e-c coupling, and some have extremely large and
rapid Ca2 transients upon stimulation (for example, the
toadfish swim bladder muscle, which contains only RyR1;
O’Brien et al., 1993; Rome et al., 1996). Although physio-
logical studies in RyR3 knockout mice show some modest
impairment of tension development during early postnatal
muscle development, muscle differentiation and e-c cou-
pling appear normal (Barone et al., 1998). On the other
hand, no example of skeletal muscle lacking RyR1 expres-
sion is known to exist in nature, and muscles with null
mutations of RyR1 all show total failure of e-c coupling and
poor development. This is especially evident in the mouse,
where RyR3 is not normally abundant (Takeshima et al.,
1994; Buck et al., 1997), and in the chicken, where the
-isoform (equivalent to RyR3) is normally present with the
-isoform (equivalent to RyR1) in approximately equal
amounts (Airey et al., 1990, 1993a; Ivanenko et al., 1995).
In view of the above observations, it has been proposed that
RyR3 may play a less direct role during e-c coupling,
perhaps being secondarily activated after the opening of
RyR1 (Rios et al., 1991).
It is important to know what role RyR3 may play in the
structural organization of calcium release units. A direct
opportunity to make such an inquiry is offered by 1B5 cells,
a mouse skeletal line that carries a null mutation for RyR1.
Differentiated 1B5 cells express several CRU proteins, but
neither RyR1 nor RyR3 (Moore et al., 1998). The cells
develop a SR system that makes junctions with the surface
membrane and with primitive transverse (T) tubules, despite
the lack of RyRs (Protasi et al., 1998). These junctions
contain triadin and DHPRs, but of course lack RyRs or feet,
and thus are dyspedic CRUs (dCRUs). These CRUs do not
permit Ca2 release in response to depolarization, caffeine,
or 4-m-chloro-cresol (Moore et al., 1998; see also the ac-
companying report, Fessenden et al., 2000). Dyspedic
CRUs in 1B5 cells resemble the great majority of dCRUs in
the developing myotubes of RyR1-null mice, which develop
in the absence of RyR1 and in the presence of very low
levels of RyR3 (Takeshima et al., 1994; Takekura et al.,
1995a; Takekura and Franzini-Armstrong, 1999). In CRUs
of normal skeletal muscle cells, RyRs and DHPRs are
arranged in highly ordered arrays with related parameters.
RyRs are disposed in a tetragonal arrangement, and groups
of four DHPRs, or tetrads, are associated with alternate
RyRs, forming a related array (Franzini-Armstrong and
Nunzi, 1983; Block et al., 1988; Franzini-Armstrong and
Kish, 1995; Protasi et al., 1997). In 1B5 cells, despite the
absence of RyRs, both DHPRs and triadin maintain their
ability to form discrete groups located at dCRUs. However,
DHPRs do not maintain the normal tetradic arrangement
(Protasi et al., 1998). Arrays of DHPR tetrads can be re-
stored in differentiated 1B5 cells by transfection with RyR1
cDNA, indicating that the formation of tetrads requires
anchoring of DHPRs on RyR1s (Protasi et al., 1998). In the
present study we characterize in detail the effect of RyR1
expression on CRU structure, and, in addition, we define the
effect of RyR3 expression. We find that both RyR1 and
RyR3 are appropriately targeted to junctional sites, so that
their cytoplasmic domains are located between the SR and
exterior membrane, bridging the gap between the two. Both
RyR1 and RyR3 are arranged in ordered arrays in the
junctional SR in the absence of the other isoform. However,
while expression of RyR1 restores the formation of DHPR
tetrads in the surface membrane, expression of RyR3 does
not, suggesting that RyR3 does not link to DHPRs at the
junctions. Similar cultures transfected with RyR3, using the
same helper free transduction system, have been shown by
others to produce functional protein that undergoes sponta-
neous Ca2 release, caffeine-induced Ca2 release, but not
depolarization-induced e-c coupling (Ward et al., 2000;
Moore et al., 1999; see also the accompanying paper, Fes-
senden et al., 2000).
MATERIALS AND METHODS
Cell culturing
The methods used to create the 1B5 cell line are described in detail
elsewhere (Moore et al., 1998). The cells were expanded at 37°C in
low-glucose DME medium containing 20% fetal bovine serum, 100
units/ml penicillin, 100 g/ml streptomycin, and additional 2 mM L-
glutamine (growth medium). After 48 h the cells were replated on
thermanox coverslips (Nunc, Naperville, IL) covered with Matrigel (Col-
laborative Biomedical Products, Bedford, MA). When they reached 70%
confluence, growth medium was replaced with differentiation medium
(containing 2% heat-inactivated horse serum instead of 20% of fetal bovine
serum) to induce differentiation. The medium was changed every day, and
the cells were fixed 5–6 days later.
cDNA packaging in HSV-1 virions and
cell transfection
RyR1 and RyR3 cDNAs were packaged into HSV-1 amplicon virions,
using the helper virus-free packaging system. The methods are described in
detail elsewhere (Fraefel et al., 1996; Wang et al., 2000). Four to five days
after differentiation had begun, the cells were infected with 1 ml of
differentiation medium containing HSV1 virions at 4  105 infectious
units/ml (a moiety of infection of 3). This mixture was removed 2 h
later and replaced with 2 ml of differentiation medium. The cells were
fixed 24 h after infection.
Preparation of RyR3 site-directed antibody
A polyclonal antibody (RyR3-Ab) against a 13-amino acid region specific
for RyR3 and containing a C-terminal cysteine (KKRRRGQKVEKPEC)
was prepared using standard procedures. One milligram of keyhole limpet
hemocyanin-conjugated peptide was injected into a rabbit. The antisera
were collected after 14 days post-injection of the third to fifth boost. RyR3
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antibody was affinity purified using a peptide-agarose column prepared
using Sulfo-Link gel (Pierce, Rockford, IL).
Immunoblotting the RyR3 antibody
Diaphragm and cardiac SR microsomes were denatured in sodium dodecyl
sulfate (SDS) sample buffer (2% SDS, 2%, b-mercaptoethanol, 0.1 M
Tris-HCl (pH 6.8), 10% glycerol) for 5 min at 95–100°C, separated on
3–12% SDS polyacrylamide gels, and transferred to Immobilon-P mem-
branes at 4°C at 400 mA for 1–3 h followed by 1A for 14–16 h.
Membranes were blocked for 1 h at room temperature with 5% nonfat dry
milk and 0.1% Tween 20 in phosphate-buffered saline (PBS) and incubated
for 3 h at room temperature with either RyR3-Ab or a monoclonal antibody
specific for RyR1 (D110; Gao et al., 1997) in PBS containing 1% nonfat
dry milk and 0.1% Tween 20. After washing, the bound antibody was
detected with horseradish peroxidase-conjugated anti-rabbit or anti-mouse
IgG, using 3,3-diaminobenzidine and H2O2. Fig. 1 shows immunoreactiv-
ity of the polyclonal antibody specific for RyR3 in diaphragm muscle (lane
2). The very minor amount of RyR3 in cardiac muscle cannot be detected
using these loading conditions (lane 1). A specific anti-RyR1 antibody
detected a band that runs slightly higher than RyR3 (lane 3).
Immunohistochemistry
The cells were fixed in methanol for a minimum of 20 min at 20°C,
blocked in PBS containing 1% BSA and 10% goat serum for 1 h, and
incubated first with primary antibodies and then with secondary antibodies
(conjugated to cyanine 3 (CY3), Texas Red (TR), or fluorescein isothio-
cyanate (FITC); Jackson ImmunoResearch Laboratories, Lexington, KY),
respectively, for 2 h and 1 h at room temperature. Code, specificity,
working dilution, original reference, and the sources of primary antibodies
are as follows: 34C, recognizes both RyR1 and RyR3, 1:10, Airey et al.
(1990), Developmental Studies Hybridoma Bank (University of Iowa); no.
5, anti-RyR1, 1:200, Flucher et al. (1993), gift of Dr. S. Fleischer; RyR3-
Ab, anti-RyR3, 1:100, characterized in this paper; 21A6, anti-1DHPR,
1:250, Morton and Froehner (1987), Chemicon International (Temecula,
CA); GE4.90, anti-triadin, 1:500, Caswell et al. (1991), gift of Dr. A. H.
Caswell. The specimens were viewed either in an inverted fluorescence
microscope (Olympus IX70) or in a scanning confocal microscope
(LSM510; Carl Zeiss, Switzerland).
Electron microscopy
The cells were washed twice in PBS at 37°C, fixed in 3.5% glutaraldehyde
in 0.1 M sodium cacodylate buffer (pH 7.2), and then kept in fixative for
up to 1–4 weeks at 4°C before further use. For thin sectioning the cells
were postfixed in 2% OsO4 for 2 h at room temperature and then contrasted
in saturated uranyl acetate either for 4 h at 60°C or overnight at room
temperature. The samples were embedded in Epon 812, and the sections
were stained in uranyl acetate and lead for 8 min each.
For freeze fractures the glutaraldehyde-fixed cells were infiltrated with
30% glycerol. A small piece of the coverslip was mounted with the cells
facing a droplet of 30% glycerol, 20% polyvinyl alcohol on a gold holder
and then frozen in liquid nitrogen-cooled propane (Cohen and Pumplin,
1979; Osame et al., 1981). The coverslip was flipped off to produce a
fracture that followed the culture surface originally facing the coverslip.
The fractured surfaces were shadowed with platinum unidirectionally at
45° and then replicated with carbon in a freeze-fracture apparatus (model
BFA 400; Balzers S.p.A., Milan, Italy). Sections and replicas were pho-
tographed in a 410 electron microscope (Philips Electron Optics, Mahwah,
NJ).
Data and measurements
Data were obtained from the following databases. For control cells, the
database from a previous study (Protasi et al., 1998) consisted of 13 freeze
fractures from eight differentiated cultures and five embeddings from three
cultures. In addition, one freeze fracture was performed on a nontrans-
fected culture in the present study, and 16 coverslips (from 16 cultures) and
12 coverslips (from 12 cultures) were immunolabeled, respectively, with
anti-1s-DHPR antibodies and anti-triadin. For RyR1 and RyR3 infections,
34 coverslips (from 21 cultures) and 20 coverslips (from 13 cultures) were
immunolabeled, respectively, with anti-RyR antibodies. For RyR1 infec-
tions, six freeze-fracture runs were performed on dishes from five cultures,
and four embeddings were made from four separate dishes in two different
cultures. For RyR3, six freeze-fracture runs were performed on five dishes
from five different cultures, and four embeddings were made using four
dishes from four different cultures. The culture dishes used for electron
microscopy (EM) were parallel to cultures that showed positive RyR
labeling.
Quantitative data were obtained as follows:
1. The number of cells with various aspects of protein expression and/or
arrangement (see Results) was estimated from counts of cells through
direct view of immunolabeled specimens in the epifluorescence micro-
scope (see Table 1).
2. The width of the junctional gap was measured in images of dCRUs
and CRUs, in which both the SR and surface membranes were clearly
delineated, indicating an appropriate orientation of the membranes perpen-
dicular to the plane of sectioning. Junctions fitting these criteria were
selected from a series of micrographs depicting all junctions that could be
seen in various sections, until a total reached 20 junctions in each category.
Three to four lines were drawn randomly across the junction, and mea-
surements were taken at the position of these lines.
3. The spacings between feet were measured in junctions showing
several (three to nine) evenly spaced feet within the junctional gap. The
average distance was calculated by dividing the distance between the most
widely separated feet by the number of feet in the group minus one. All
available junctions, up to a total of 30, were measured.
4. The spacing between DHPR tetrads in RyR1 transduced cells were
measured in micrographs from groups of tetrads that were selected for
being most complete. The location of incomplete tetrads was estimated by
the dotting approach (see Protasi et al., 1997).
5. The method for estimating frequency of tetrads is explained in the
Results.
FIGURE 1 Immunoblots of cardiac and diaphragm microsomes. Lane 1:
Cardiac microsomes and polyclonal RyR3 antibody. Lanes 2 and 3: Dia-
phragm microsomes, polyclonal RyR3 antibody, and monoclonal RyR1
D110 antibody. The polyclonal RyR3 antibody shows reactivity with
diaphragm RyR3 (lane 2) but not with cardiac RyR2 (lane 1) or the slightly
slower migrating RyR1 in the diaphragm (lane 3). The minor amount of
RyR3 in cardiac muscle cannot be detected under these loading conditions
(lane 1).
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Preparation of figures
Pictures and negatives were scanned using a Color Flatbed Scanner UMAX
Power Look II at 300 dpi. Figures were mounted using Adobe Photoshop,
v. 4.01, and labeled using Canvas, v. 3.5.4 (Deneba Software).
RESULTS
Formation of RyR-containing CRUs in RyR1- and
RyR3-infected cells
1B5 cells were immunolabeled with antibodies against two
proteins of the junctional SR, RyR and triadin, and one
protein of the surface membrane/T tubule, the 1s subunit of
the DHPR.
Differentiating 1B5 cells fuse into large multinucleated
myotubes. Five days after the withdrawal of growth factors,
most of the multinucleated myotubes and some of the re-
maining unfused cells express 1s-DHPR and triadin (Fig.
2, A and B). The two proteins are clustered in intensely
fluorescent small foci located at, or very close to, the cell
surface (see Protasi et al., 1998). 1B5 cells do not express
any detectable amount of either RyR1 or RyR3 (Moore et
al., 1998) and are negative for labeling by an anti-RyR
antibody that recognizes both isoforms (Figs. 2 C and 3 B).
We have previously defined a relationship between the
formation of large multinucleated myotubes, the presence of
dCRUs (dyspedic peripheral couplings, dyads, and triads),
and the presence of DHPRs and triadin foci (Protasi et al.,
1998). 1B5 cells that fuse into myotubes form dCRUs,
structures that are specific to muscle fibers, and express
triadin and DHPRs, two skeletal muscle-specific proteins.
These cells are clearly differentiated, according to the clas-
sic definition of differentiation. 1B5 cells have defective
myofibrils and dyspedic CRUs that lack feet (Protasi et al.,
1998). In these two respects 1B5 cells resemble the in vivo
differentiated myofibers found in RyR1-null embryos
(Takekura et al., 1995a).
Infection of 1B5 cells with HSV-1 amplicon virions
containing a cDNA encoding either RyR1 or RyR3 gave
excellent results, in both transduction efficiency and protein
expression. In addition, HSV-1 amplicon virions did not
cause any cell death and did not affect either general struc-
tural parameter, such as cell size and shape, or the level of
differentiation (see below). Up to 60–70% of the myotubes
examined 24 h after infection reacted positively with anti-
RyR antibodies in both RyR1- and RyR3-infected cultures
(Figs. 3, C and D). This is in agreement with data obtained
independently from comparable viral titers (presented in the
accompanying paper; Fessenden et al., 2000). The presence
of RyR expression in the cells did not appear to change the
expression of DHPR and triadin and their formation of foci
(Figs. 3 A and 5). Nondifferentiated cells act as negative
controls for the DHPR and triadin antibodies, and differen-
tiated cells that do not express RyRs act as negative controls
for the RyR antibodies. Examples of the latter are shown in
Figs. 2 C and 3 B. A negative control for the secondary
antibody is also shown in figure 2 D of Protasi et al. (1998).
Microscopic examination of multinucleated myotubes at
high optical resolution revealed that transduction with either
RyR1 or RyR3 produced similar small, intense RyR foci,
which form a punctate pattern at the periphery of the cell,
either at the surface or in its vicinity (Fig. 4, A and C). The
interior of cells exhibiting foci is practically devoid of any
RyR antibody labeling, as clearly shown in images through
the center (Fig. 4 B). Double labeling for RyR and either
DHPR or triadin demonstrates colocalization of foci of the
latter two junctional proteins with foci of either RyR1 or
RyR3. Fig. 5 illustrates cells transduced with RyR1 (Fig. 5,
A–D) and RyR3 (Fig. 5, E–H) and double labeled for RyR
(shown in red) and either DHPR or triadin (shown in green).
The DHPR/triadin-positive foci also containing RyR appear
as yellow spots (Fig. 5, B, D, F, and G). Cells that have only
green foci (either DHPR or triadin) and no evidence of RyR
presence (Fig. 5, A, C, and E) are identical to cells in control
FIGURE 2 Expression and localization of
DHPR and triadin in differentiated 1B5 cells.
(A and B) Immunolabeling of 1B5 cells 5
days after differentiation with antibodies
against 1-DHPR and triadin shows that most
of the large myotubes contain frequent, dis-
crete foci of the two proteins at or near the
cell surface. Undifferentiated cells do not ex-
press either DHPR or triadin (not shown). (C)
An antibody that recognizes both RyR1 and
RyR3 (34C) shows an absence of both iso-
forms (fluorescence microscope Olympus
IX70). Bar, 25 m.
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cultures (see Protasi et al., 1998), and thus they obviously
are not transduced. Cells that express triadin, DHPRs, and
the induced RyR are both differentiated and transduced.
In thin-section electron microscopy, differentiated 1B5
cells are identified by the presence of peripherally located
SR-exterior membrane junctions that lack feet (dCRUs), as
previously described (see Protasi et al., 1998). The dCRUs
are typically found in the larger cells, and they are either in
the form of peripheral couplings or of dyads/triads involv-
ing wide and short surface membrane invaginations (prob-
ably representing primitive T-tubules). A correlation be-
tween the presence of dCRUs and that of foci of triadin and
DHPRs has previously been established (Protasi et al.,
1998). Partially developed myofibrils are often but not
always present, and endoplasmic reticulum (ER) networks
in the cell interior are very scarce in differentiated 1B5 cells.
In thin sections of transduced cultures, differentiated cells
also contain numerous peripherally located dCRUs, but
scarce internal SR, and often some myofibrils, resembling
the differentiated cells in control cultures. The novel feature
introduced by the RyR transduction is the appearance of feet
in the SR-surface junctions of some cells. The feet are
clustered within CRUs, and in most cases the spacing be-
tween them is quite regular, indicating the formation of
ordered arrays in both RyR1- and RyR3-transduced cells
(Fig. 6, arrows). The spacing between feet is 31  3 nm in
RyR3-infected cells and 36  6 nm in RyR1-infected cells
(mean  1 SD from 30 junctions each). For each junction
the measured spacing is the average of the spacing between
three to nine adjacent feet. The data were obtained from
embeddings of four dishes (four independent infected cul-
tures) in the case of RyR3 and from embeddings of four
dishes (two independent infected cultures) in the case of
RyR1. The spacing in RyR1-expressing cells is greater and
more variable than in RyR3-expressing cells, probably be-
cause of the interesting fact that most of the RyR1 junctions
have smaller clusters of feet and thus the measurements are
less accurate.
Clusters of feet of both isoforms are found within CRUs
that are located at or very near the surface membrane and
are almost never seen in the center core of the cell. This is
in perfect agreement with the location of RyR/DHPR/triadin
foci detected by immunolabeling (Figs. 4 and 5). In addi-
tion, there is a bimodal distribution of CRUs, i.e., all CRUs
in a given cell either are dyspedic (dCRUs; Fig. 5, D and H)
or contain feet (RyR CRUs; Fig. 5, A–C and E–G). This
also correlates well with the immunofluorescence observa-
tions showing that after infection with RyR virion differen-
tiated cells have either no RyR foci or abundant RyR foci
throughout. Two to three cells (among the several hundred
observed in this set of experiments) presented an internal set
of SR cisternae, the surfaces of which were studded with an
extensive array of feet (not shown) of the type previously
described in RyR1-transfected Chinese hamster ovary cells
(Takekura et al., 1995b).
RyR and dCRUs in different cells from the same cul-
tures differ in the width of the gap separating the SR and
exterior membranes. The dyspedic junctional gap is nar-
rower and more variable in width than the RyR gap, in
agreement with previous observations on dyspedic and nor-
mal junctions of mouse muscle in vivo (Takekura et al.,
1995a) and with the narrow gap of control 1B5 cells (Protasi
et al., 1998). The difference is quite obvious to the eye (Fig.
6; compare dyspedic junctions to RyR junctions). The gap
width was measured in junctions from RyR1- and RyR3-
infected cells that were either RyR or dyspedic. The mea-
sured widths were 12.4  2.0 for the RyR3 and 12.2  1.9
FIGURE 3 DHPR and RyR expression in RyR-transduced 1B5 cells.
Five days after differentiation, 1B5 myotubes in RyR-transduced cultures
express 1-DHPR (A) and either RyR1 (C) or RyR3 (D). (B) Control cells
stained with anti-RyR antibodies demonstrate lack of expression before
exposure to HSV-1 virions. Protein distribution and colocalization of
DHPRs and RyRs are shown in Figs. 4 and 5. Statistical analysis is given
in Table 1. Anti-RyR antibody used: 34C (fluorescence microscope Olym-
pus IX70). Bar, 200 m.
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for the RyR1-containing junctions and 9.1  3.6 nm and
9.3  3.1 for the dyspedic junctions in the same embeddings
(mean  1 SD, from 20 junctions, two to four measurements
at each junction). The width of the combined RyR junctions
is significantly different from that of the combined dyspedic
junctions (Student’s t-test, p  0.0001), but the widths of
junctions containing RyR1 and RyR3 do not differ.
Interestingly, a variation in the en bloc staining procedure
for EM resulted in a junctional gap width that is not differ-
ent in dyspedic and RyR CRUs. In the different procedure,
RyR1- and RyR3-infected 1B5 cells had been exposed to
uranyl acetate in 70% EtOH rather than the laboratory’s
standard procedure involving aqueous solution. The widths
of the junctional gaps for control, RyR1, and RyR3 junc-
tions in these cells are approximately equal to each other:
11.4  2.1, 11.4  2.1 and 11.5  1.2 nm (from 20, 27, and
14 junctions; 80, 135, and 70 measurements). The significance
of this is considered at the end of the Discussion.
It is known that RyR-containing CRUs can form in dys-
genic muscle cells lacking 1s-DHPR, and thus it is not
surprising that few cells (less than 1%) in cultures trans-
duced with either type of RyR have red foci with no evi-
dence for the presence of DHPRs (not shown). These cells
are transduced, and the RyRs are located in peripherally
placed foci that contain very little or no DHPR (not shown).
While the colocalization with triadin was ubiquitous in cells
transduced with RyR1 (Fig. 5 D), some cultures transduced
with RyR3 showed few cells (again less than 1%) with
RyR3 foci, and either no or an undetectable level of triadin
(Fig. 5 H). Note, however, that in most cells expressing
RyRs in the absence of DHPR/triadin foci the RyR remain
located within the internal reticular ER network.
Transduced undifferentiated cells
Numerous mononucleated cells and a few of the larger
multinucleated myotubes in the cultures infected with either
RyR isoform contain an extensive reticular network pervad-
ing the entire cell, presumably the endoplasmic reticulum,
which is intensely labeled by the antibody (Fig. 7 A).
Coexistence of the internal-reticular and the peripheral-
punctate patterns of RyR labeling is very rare (Fig. 7 B). In
double immuno labeling the cells with an intense RyR internal
labeling and no peripheral RyR foci lack DHPR and/or triadin
foci (Fig. 5 E), suggesting that these cells are not differentiated.
The presence of the internal intensely RyR network corre-
lates well with the presence of numerous extended rough ER
cisternae in EM images from cells of infected cultures (com-
pare Fig. 7, A and C). The ER cisternae form part of a network
pervading the whole cell and containing a granular material
(Fig. 7 D). Such extended rough ER (rER) cisternae, forming
complex networks, are never present in noninfected cells,
which have fewer and much smaller isolated rER profiles (see
figure 4 A in Protasi et al., 1998). In agreement with immu-
nolabeling, the cells containing the extended ER network are
usually smaller and lack evidence of differentiation (CRUs and
myofibrils). We note that obvious arrays of feet are not visible
on the surface of the extensive ER network in these cells, but
the presence of a few randomly distributed individual feet
cannot be excluded. Considering the excellent quantitative
correlation between morphology in the present study (Fig. 7 A)
and functional recovery presented in the accompanying paper
(Fessenden et al., 2000), it is likely that cells possessing a
reticular pattern of RyR distribution are the same cells that fail
to have e-c coupling but recover responses to caffeine. On the
basis of the functional data and of the lack of CRUs, the cells
are classified as transduced undifferentiated. They are not
considered further in this study.
Quantitation of immunolabeled cultures
Clustering of DHPRs and the formation of ordered DHPR
arrays are detected by freeze fracture, and two points about
this method need to be considered. First, this technique
samples 3-mm circles, which are small portions of the
coverslip on which cells are cultured. Second, the position-
FIGURE 4 RyR1 and RyR3 distribution in
transduced, differentiated myotubes. (A and C)
Both RyR isoforms are clustered within in-
tensely labeled foci. Images through the center
(B) and at the bottom surface (C) of the same
cell show that the foci are located at or very
close to the cell surface. Punctate labeling for
RyR is present in large myotubes and in some
smaller, spindle-shaped cells that are also
multinucleated. Anti-RyR antibody used: 34C
(fluorescence microscope Olympus IX70). Bar,
25 m.
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FIGURE 5 Immunolabeling for RyR1/RyR3 (shown in red) and either DHPR or triadin (shown in green). Yellow indicates colocalization of RyR and
DHPR/triadin. (A and C) Cells with yellow peripheral foci contain both RyR1 and DHPR (or triadin). These cells are transduced and differentiated. Green
cells contain only DHPR (or triadin) but no RyR; these cells are differentiated, but not transduced. (B and D) RyR1 colocalize with either DHPR or triadin
at peripherally located foci. Cells expressing a high level of RyR1 but little or no DHPR/triadin are not shown. (E) RyR3-transduced cells expressing either
RyR3 (red cells) or DHPR (green cells) or both proteins (yellow cells). (F and G) Colocalization of RyR3 with either DHPR or triadin is obvious in these
transduced and differentiated cells. (H) A rare cell that has peripheral foci containing RyR3 but not triadin, showing that RyR may be appropriately targeted
to CRUs in the absence of triadin. Anti-RyR1 antibody used: no. 5; anti-RyR3 antibody used: RyR3-Ab (LSM510 confocal microscope; Carl Zeiss). Bars:
A, C, and E, 50 m; B, D, F, G, and H, 25 m.
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ing of DHPR within clusters is the same in control and
RyR3-infected 1B5 cells (see below). For these two reasons,
it is very important to know that a sufficiently large number
of differentiated-transduced cells are present within small
areas of the coverslip. We obtained quantitative data on the
frequency of various types of cells in infected cultures,
using coverslips grown and treated in parallel with those
used for freeze fracture. Coverslips from a culture dish were
cut in half, and the two halves were stained either for DHPR
or for RyR. Other coverslips from the same culture were
FIGURE 6 RyR1 and RyR3 are equally capable of forming arrays of feet. In RyR1- and RyR3-infected dishes, differentiated cells fall into two categories.
Some cells have peripherally located CRUs that contain ordered arrays of feet (arrows; A–C, RyR1; E–G, RyR3). Other cells (D and H) exclusively have
junctions with no feet (dyspedic). These two types of cells correspond to the transduced-differentiated and differentiated categories in Table 1. In these
images the width of the junctional gap is wider in junctions containing feet than in dyspedic ones (compare A–C and E–G with D and H), but under different
preparative procedures the width may be the same (see Results and Discussion). Bar, 0.1 m.
FIGURE 7 RyR1 and RyR3 remain in the endoplasmic reticulum of undifferentiated cells. (A) Several small cells expressing RyR1 and RyR3 show an
extensive, reticular network in the cytoplasm, which labels with antibodies against RyR (arrows). (B) In very few cells the internal reticular and peripheral
punctate RyR labeling coexist. We correlate the cells presenting the reticular network in the cytoplasm (such as the one in A) with cells containing an
extensive rough ER (rER) network pervading the whole cytoplasm and filled with a grainy material (C and D, arrows). Cells with the extended internal
rER do not have CRUs at their periphery (not differentiated) and are present only in infected cultures. Anti-RyR antibody used: 34C (LSM510 confocal
microscope; Carl Zeiss). Bars: A and B, 25 m; C and D, 0.25 m.
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fixed for freeze fracture and thin sectioning. The number of
cells per field of view that had labeled foci were counted in
coverslips from five randomly chosen and well-differenti-
ated cultures of cells transduced with virions containing
either RyR1 or RyR3. The data are given in Table 1.
Column 4 gives the counts of cells with peripheral foci of
DHPR/triadin, which represent the number of differentiated
cells. Column 5 gives the total number of cells that express
RyR1 or RyR3. These numbers include cells with peripheral
punctate and internal reticular patterns of RyR distribution.
Column 6 gives the count of cells with a punctate pattern of
peripheral RyR foci. These cells are both differentiated and
transduced. The ratio between the number of differentiated
and transduced-differentiated cells is given in column 7, and
column 8 gives the ratio between transduced-differentiated
cells and total number of transduced cells. In four experi-
ments, approximately two out of three differentiated cells
are also transduced. This means that in two out of three cells
that show clusters of DHPRs in the freeze-fracture replica of
the DHPR clusters are located in correspondence or RyR
CRUs. One RyR1 experiment was less successful (RyR1
no. 2), but even here, one out of four cells was transduced.
The EM grid covers an area that is approximately nine times
larger than the field of view of the 40 objective, and thus
a significant number of cells that are differentiated and
transduced should be present in each EM sample. Taken
together with the data of Moore et al. (1998), these results
reveal that these multinucleated myotubes forming RyR1
foci are capable of sustaining e-c coupling.
DHPR arrangement in CRUs of cells expressing
RyR1 and RyR3
Numerous previous publications have demonstrated that
DHPRs are present in the surface membrane as large parti-
cles located within uniquely identifiable clusters that are
easily visible in freeze-fracture replicas (Block et al., 1988;
Takekura et al., 1994; Protasi et al., 1997, 1998).
Distribution of DHPRs in RyR1-transduced cultures will
be described in detail first, because this helps in understand-
ing results from RyR3-transduced cells. Clusters of DHPRs
in RyR1-transduced cells are located within well-delimited
patches of membrane (Fig. 8 A), which mostly exclude
other, smaller intramembranous particles. All clusters of
DHPRs contain some recognizable tetrads, defined as
groups of four equal particles (each representing one
DHPR) located at the corners of small squares (see details in
Fig. 8). Other groups of DHPRs within the clusters are
recognizable as incomplete tetrads that contain three parti-
cles occupying three corners of a square (see detail in lower
right corner of Fig. 8 A). The centers of complete and
incomplete tetrads mark an orthogonal pattern with a spac-
ing of 41.2  8.5 nm (mean  1 SD from 25 clusters of
tetrads). Extending the pattern through the whole group of
particles shows that all particles within the groups of
DHPRs are located in close proximity to a tetrad center (Fig.
8 B). Along the diagonals of the tetragonal arrangement the
average spacing is 58 nm (Fig. 8 B, arrows), which corre-
sponds to twice the center-to-center distance between two
adjacent feet. This ordered arrangement is identical to that
found in normal skeletal muscles as well as in a muscle cell
line (Block et al., 1988; Franzini-Armstrong and Kish,
1995; Protasi et al., 1997). A prominent feature of DHPR
arrays in cells infected with RyR1 is the alignment of
particles along two orthogonal directions that arises from
the stereotyped positioning of individual DHPRs relative to
the underlying subunits of RyRs (see Discussion and Block
et al., 1988; Franzini-Armstrong and Kish, 1995).
We find three correlations between the distribution of
tetrad arrays in freeze-fracture replicas and that of immu-
nolabeled foci of RyRs. One is a 1:1 correspondence be-
tween cultures that show RyR foci and those that show
TABLE 1 Frequency of cells positive for DHPR/triadin and for RyR, and of cells with a punctate RyR pattern
1
Culture
2
Antibody
3
Fields of
view
counted
4
No. of cells with
DHPR/triadin in foci
(differentiated)
5
No. of cells
expressing RyR
(total transduced)
6
No. of cells with
punctate RyR foci
(transduced-
differentiated)
7
Ratio of differentiated to
transduced-differentiated
8
Ratio of transduced-
differentiated to total
transduced
RyR1 1a Anti-DHPR 53* 144 (2.7) 1.2 0.49
RyR1 1a Anti-RyR 53* 240 117 (2.2)
RyR1 1b Anti-DHPR 53* 195 (3.7) 1.5 0.47
RyR1 1b Anti-RyR 53* 276 130 (2.5)
RyR1 2 Anti-DHPR 25† 165 (6.6) 4.4 0.43
RyR1 2 Anti-RyR 25† 86 37 (1.5)
RyR3 1 Anti-DHPR 57* 159 (2.8) 1.7 0.28
RyR3 1 Anti-RyR 53* 300 85 (1.6)
RyR3 2 Anti-triadin 22† 101 (4.6) 1.2 0.70
RyR3 2 Anti-RyR 22† 128 90 (4.1)
*Indicates counts taken with 40 objective.
†Indicates counts taken with 63 objective.
In parentheses, the number of cells per field of view.
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clusters of tetrads in fractures from parallel dishes. The
second correlation is in the frequency of cells that have
either structure. Replicas from culture dishes parallel to
those used for RyR1 1a and b immunolabeling (see Table 1)
show many (14–16 per EM grid) cells with surface clusters
of DHPRs disposed in arrays of tetrads, some of them quite
extensive (Fig. 8 A). On the other hand, a culture dish
parallel to the RyR1 no. 2 experiment in Table 1, which had
a lower number of transduced cells with RyR foci, showed
fewer (two or three per EM grid) cells with tetrads after
freeze fracture. The third correlation is in the distribution of
tetrad arrays and foci in individual cells. Both freeze frac-
ture and immunolabeling show a bimodal distribution in the
sense that individual cells have either a large number of
tetrad clusters per focus or none. These three correlations
indicate that the presence of RyR1 foci has a predictive
value for the presence of arrays of DHPR tetrads. This, of
course, is also demonstrated by the colocalization of the two
proteins shown by double immunolabeling (Fig. 5, A
and B).
Fractures of RyR3-transduced cultures contain numerous
myotubes with clusters of DHPRs, but no tetrads are seen in
these junctions. In addition, there is no preferred linear
alignment of the DHPR particles along orthogonal direc-
tions, indicating that the position of the majority of particles
is not correlated to that of feet subunits. The clusters of
DHPRs in cultures containing RyR3-transduced cells (Fig.
8, C–E) and in control cultures (Fig. 8, F and G) are not
structurally different, except for a slightly domed shape of
the membrane in some images from the transduced cells.
The similarity between DHPR clusters of control and RyR3-
transduced cultures raises the questions of whether the
DHPR clusters detected by freeze fracture belong to cells
that have been transduced with RyR3 and whether they
correspond to foci of DHPRs that are colocalized with
RyRs. The first part of the question is answered by the
observation that cells with peripherally located RyR3 clus-
ters constitute a considerable portion of the cells exposed to
RyR3-containing virions. The ratio of differentiated cells
(containing DHPR foci) and transduced-differentiated cells
FIGURE 8 Infection with RyR1, but not
RyR3, induces DHPR tetrad restoration in dif-
ferentiated 1B5 cells. (A) In RyR1-transduced
cells DHPR particles are grouped into tetrad
arrays. Two tetrads are outlined by squares;
these are shown at a higher magnification (A,
lower corners). Some of the tetrads are in-
complete; that is, one (or more) of the four
elements is missing. A set of four complete
tetrads is shown at on right side of B. (B)
Dotting the center of each tetrad in the array
of A results in an ordered orthogonal arrange-
ment of dots. The spacing between the dots
marking the center of tetrads in the direction
of the arrows is twice the distance between
feet, indicating that the normal skeletal 2:1
ratio between feet and tetrads is restored in
these CRUs. (C–G) In RyR3-transduced and
control cells, even if DHPR particles are clus-
tered within junctional domains, they do not
form tetrads. Bars, 0.1 m.
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(containing RyR) is 3:2 (Table 1, column 7). The second
part of the question is answered by the observation that
either all or many of the DHPR foci are colocalized with
RyR foci in the majority of the cells that were demonstrated
to have foci of both proteins (Fig. 5 F). In our freeze-
fracture replicas the entire cell surface facing the coverslip
is visible and has been examined. Thus it is unlikely that
co-localized DHPR and RyR3 clusters have been missed in
this study.
Testing the random disposition of DHPRs in
RyR3-expressing cells
Despite the fact that the disposition of DHPRs appears
random in RyR3-transduced cells, it is possible that a small
percentage of DHPRs are specifically linked to feet, thus
acquiring a specific location relative to the feet arrays. To
test for this possibility, the disposition of particles was
assessed in DHPR clusters of RyR3-expressing cells versus
those in control, and RyR1-expressing cells. Control cells
provide parameters for a randomly generated arrangement
of particles, while RyR1 cells provide parameters for tetrad
arrays derived by steric linking of RyRs to feet subunits.
First we determined the frequency of tetrads in clusters
from the three types of cells. We examined in detail 27
clusters of particles containing a total of 1170 particles (for
control cells), 973 particles (for RyR3), and 716 particles
(for RyR1). In the arrays from RyR1-transduced cells, 83%
of the particles on average are part of complete tetrads or of
tetrads containing three of the four DHPRs. The remaining
particles are also part of tetrads, as indicated by their ap-
propriate position in the array, but the tetrads in this case are
reduced to two elements or one element. Note that most of
the tetrads have a precise arrangement of particles (see
details in Fig. 8), even if some are distorted during fractur-
ing. In clusters from RyR3-infected cells and from control
cells an average of 19% and 6% particles, respectively, is in
groups that resemble tetrads, and in most of the groups of
four particles the square disposition is highly distorted.
Second we determined whether a significant number of
particles are aligned at spacing and along directions indic-
ative of a possible interaction with feet subunits. Three
parameters were measured for this analysis. Parameter A
was the number of particles that are arranged in short linear
arrays of three or more particles. In control cells, the per-
centage of particles that are aligned in groups of three to
five is 28  8 of the total (mean  1 SD, from a total of
1534 particles, in 24 clusters from four freeze fractures). In
RyR3- and RyR1-expressing cells, the percentages are 15
10 and 84  24, respectively (from 3149 particles, 50
clusters, and five freeze fractures for RyR3; and 719 parti-
cles, 24 clusters, and one freeze fracture for RyR1). The
differences between the means for RyR1 and RyR3 versus
control are both significant (p  0.0001), but the absolute
values of the differences are in opposite directions, i.e.,
clusters in RyR3 cells have fewer aligned particles than the
randomly disposed control clusters, while clusters in RyR1
cells have considerably more aligned particles than controls.
We purposely made the sample of RyR3 cells selected
larger than the others, to compensate for the fact that some
of the clusters examined may belong to cells not expressing
the ryanodine receptor.
Parameter B was the angle between lines tangent to the
linear arrays of particles. In control and RyR3 cells the
smaller of the two complementary angles at each line inter-
section was measured. The angles range from 0° to 90°, and
the mean values between 45° 25° and 49° 24° (mean
1 SD, n  141 and 166 angles). In RyR1 cells, the angles
between lines tangent to the sides of two or three adjacent
tetrads were measured. The angle sizes are tightly clustered
between 80° and 90°, with a mean of 85°  5° (n  70
angles). The differences between the means of control and
RyR3 versus RyR1 are significant (Student’s t-test, p 
0.0001), but the control and RyR3 means are not signifi-
cantly different (p  0.071).
Parameter C was the percentage of aligned groups of
particles in which the spacing between the particles corre-
sponds to that of particles associated with feet subunits. The
assessment was made by tracing the positions of particles in
adjacent tetrads of RyR1-expressing cells on a transparent
sheet and superimposing it on the aligned groups. The
percentage of aligned groups of particles with a spacing
equal to that found in tetrad arrays is 15 17% (from a total
of 24 groups) for the control and 19  24% (from 40
groups) in RyR3 cells. The difference between the two
means is not statistically significant (Student’s t-test, p 
0.389).
The conclusion from the two types of analysis is that the
arrangement of DHPR particles in RyR3-transduced cells is
not significantly different from that of control cells, but
differs considerably from that in cells that express RyR1.
DISCUSSION
Naturally occurring and engineered null mutations of RyR1
and RyR3 have provided initial information on the contri-
bution of RyR to the formation, structure, and function of
CRUs. Both in vivo and in vitro studies of specimens
lacking either one or both RyR isoforms clearly show that 1)
the formation of CRUs, in the form of SR/exterior mem-
brane junctions, and 2) the proper targeting of junctional
proteins to CRUs do not require RyRs (Takeshima et al.,
1994; Takekura et al., 1995a; Airey et al., 1993a,b; Protasi
et al., 1998; Barone et al., 1998). Because RyR3 is ex-
pressed relatively late in the differentiation process of both
murine (Bertocchini et al., 1997) and avian (Airey et al.,
1993a,b) muscles, it cannot be required either for initial
junction formation or for appropriate targeting of RyR1 to
the junctional sites. In this work we show that all of the
RyR1 expressed within the SR of differentiated 1B5 cells is
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incorporated at peripherally located junctions. Thus, RyR1
is appropriately and efficiently targeted to CRUs in the
absence of RyR3. On the other hand, published evidence
regarding the behavior of RyR3 in the absence of RyR1 is
limited. CRUs containing electron-dense material resem-
bling feet (presumably RyR3) are only 1–2% of the total
number of CRUs in the RyR1-null mouse (Takekura et al.,
1995a; Takeshima et al., 1995) and crooked neck dwarf
chicken muscles (T. Watanabe, C. Franzini-Armstrong, and
J. L. Sutko, unpublished observations). In these two systems
it is not clear whether the scarcity of such junctions is due
to low expression of the protein or to poor targeting of
RyR3 in the absence of RyR1, possibly due to muscle
dysgenesis.
Efficient expression of RyR3 in our system allows us to
show that this isoform can be as effectively targeted to
CRUs as RyR1 is, even in the absence of the latter. This
makes preferential targeting of RyR3 in dyspedic muscle
cells to sites other than CRUs unlikely. In addition, our data
show that RyR3, like RyR1, can independently form or-
dered arrays within CRUs.
Once RyRs are located in CRUs, they are in the appro-
priate position for interactions with DHPRs, which in 1B5
cells are represented by the skeletal muscle-specific 1s
isoform. Differences in the disposition of 1s-DHPR in
RyR1- and RyR3-containing CRUs have profound func-
tional implications for this interaction. The presence of
RyR1 imposes the grouping of DHPRs into tetrads, posi-
tioning of tetrads in tetragonal arrays, and consequent align-
ment of DHPRs along orthogonal lines. This specific posi-
tioning of DHPRs is characteristic of skeletal muscle
calcium release units and implies a precise relationship
between individual DHPRs and RyR1 subunits, indicative
of a stereospecific link between the two proteins. The pu-
tative site of DHPR-RyR interaction has been hypothesized
to be located between two of the domains that form the
clamp region at the corners of the RyR tetramer (Samso et
al., 1999). This would position the four DHPRs off center
relative to the RyR subunits, in agreement with previous
structural observations (Franzini-Armstrong and Kish,
1995; Protasi et al., 1997).
The colocalization of 1s-DHPR and RyR3 in double-
labeling experiments implies proximity between these two
molecules in RyR3-expressing 1B5 cells. However, our
analysis shows that the disposition of 1s-DHPRs in RyR3
cells lacks the grouping into tetrads and the alignment along
orthogonal directions that is indicative of a link to RyR
subunits. Therefore the relative positions of 1s-DHPR and
RyR3 are similar to that of 1c-DHPR and RyR2 in cardiac
muscle (Sun et al., 1995; Protasi et al., 1996). In both cases
the molecules are in close proximity to each other at the
junctions, but they are not linked in a stereospecific manner.
Despite this structural similarity, skeletal muscle fibers and
1B5 cells that express only RyR3 differ from cardiac muscle
in that e-c coupling fails, even in the presence of extracel-
lular Ca2 (Takeshima et al., 1994; Ivanenko et al., 1995).
The data in the accompanying paper (Fessenden et al.,
2000) and from Ward et al. (2000) clearly show that the
failure of e-c coupling in 1B5 myotubes expressing RyR3 is
not due to a dysfunction of the expressed RyR3. The failure
is also not attributable to differences in the functional prop-
erties of RyR2 and RyR3, because both isoforms have a
high sensitivity to Ca2 (see Franzini-Armstrong and Pro-
tasi, 1997, for a review) and thus are candidates for calcium-
induced calcium release. Instead, the probable explanation
lies in the properties of the DHPRs. 1s-DHPR has slow
activation kinetics and its Ca2 currents are almost negli-
gible, particularly when it is not linked to RyR1
On the basis of the above observations, we present mod-
els of the relative dispositions of RyRs and DHPRs in
junctions containing either one or both RyR isoforms. In all
images RyRs are shown in ordered arrays with previously
established parameters (Ferguson et al., 1984). RyR1 are
pale blue, RyR3 are green, and DHPRs are shown as black
circles. The overall disposition of feet has been shown to be
similar in muscles that contain either no RyR3 or variable
amounts of it (compare Franzini-Armstrong, 1973; Fergu-
son et al., 1984; Block et al., 1988). Thus, we assume that
the positioning of feet in the arrays is independent of the
contributions of various isoforms. Minor variations cannot
be excluded, however. In the presence of only RyR1, which
is the case in our RyR1-expressing cells as well as several
muscle types, DHPRs are grouped in tetrads (Fig. 9 A). The
four DHPRs within the tetrads (represented by four black
circles) have the same position relative to the four subunits
of the RyRs, and the tetrads are associated with alternating
feet (see Block et al., 1988). In the presence of RyR3 only
(Fig. 9 B), DHPRs are randomly grouped at the junctions.
Thus, DHPRs are located in exterior membrane domains
that face feet arrays, but, as in cardiac muscle (Sun et al.,
1995; Protasi et al., 1996), they do not have a stereospecific
position relative to the feet arrays.
In muscles that express both RyR isoforms in approxi-
mately equal stoichiometries, three arrangements of the two
isoforms are possible, and each predicts a specific position-
ing of DHPRs. One possibility is that RyR3 is precisely
alternated with RyR1 (Fig. 9 C). In this case tetrads would
be located on alternating feet, just as in Fig. 9 A. The second
possibility, based on the self-assembly property of RyR3
observed in the present study, is that RyR1 and RyR3 group
in a stochastic fashion, resulting in variable clustering of the
two types of channels (Fig. 9 D). In this case, tetrads would
be less frequent than in Fig. 9, A and C, and the large areas
devoid of tetrads would have no DHPRs (as depicted in Fig.
9 D), or, what is more likely, they would be occupied by
randomly arranged DHPRs. The third possibility (not
shown) is that the two RyRs are clustered in separate but
neighboring CRUs. Data from the literature (Airey et al.,
1990; Flucher et al., 1999) show that both RyR1 and RyR3
(or their nonmammalian equivalents) are located at triads
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but do not exclude this situation. The result of a separation
of RyRs in different CRUs would be that CRUs containing
tetrads and others with randomly disposed DHPRs would be
present in the same muscle. At the moment the precise
disposition of DHPRs in muscles with well-established high
contents of both RyR isoforms is not known, but it is clear
that once that disposition is known it will be possible to
choose between the three possibilities.
RyR3’s failure to restore either DHPR tetrads or a linear
arrangement of DHPRs along orthogonal directions demon-
strates that a specific link between RyR3 and 1s-DHPR is
either absent or quite rare. The latter observation suggests a
possible difference in the activation mechanism of RyR1
and RyR3. The accompanying paper (Fessenden et al.,
2000) indeed demonstrates that RyR3 in the absence of
RyR1 is not capable of responding to depolarization of
myotubes induced by either electrical or chemical means. It
is thus expected that RyR3 activation is secondary to RyR1
activation during e-c coupling.
The junctional gap separating the SR from surface mem-
branes in dCRUs has been reported to be significantly
smaller than the feet-occupied gap of normal junctions
(Takekura et al., 1995a), and we have confirmed this finding
(Protasi et al., 1998; present work). The narrow width of the
dyspedic gap implies that the putative docking protein re-
sponsible for holding SR and exterior membranes in close
proximity to each other is shorter than the feet, and it would
have to stretch out, break, or disappear when the feet occupy
the gap. However, we have also found that in a different
preparative procedure, the width of the dyspedic gap is
equal to the normal gap. Because shrinkage is a frequent
artifact in EM specimen preparation, particularly when little
protein is present, we suggest that the wider gap is probably
closer to reality, and the narrower gap of dyspedic junctions
does not have a functional meaning. However, the narrow
gap is useful in helping to define which junctions lack feet.
We further suggest that the docking protein, when identi-
fied, will have to be sufficiently large to cross a 10–12-nm
gap but does not have to stretch or disappear when feet
occupy the junction.
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